Key Highlights

  • SKS Technologies Group Limited designs, supplies, installs and commissions electrical, communications and audio-visual systems, historically across commercial buildings, hospitals, education facilities, stadiums and industrial sites — what the company now calls its "traditional" division.
  • Epiminder Limited is a Melbourne-based medical technology company developing Minder, a minimally invasive implantable device for continuous electroencephalography — chronic EEG — in people with epilepsy.
  • Bathurst operates four producing mines: Stockton, on the South Island's West Coast, is the export operation, producing metallurgical coal for international steelmaking markets, while Rotowaro and Maramarua in the North Island, and Takitimu in the South Island, serve the New Zealand domestic market.
  • The three businesses combine different Revenue models, Capital needs and execution priorities within the small cap stocks sector.

SKS Technologies Group (ASX:SKS), Epiminder (ASX:EPI) and Bathurst Resources (ASX:BRL) approach FY2027 from different operating positions. Their latest company disclosures show how revenue quality, cash conversion and delivery against announced programs matter more than a shared sector label.

Each company is assessed on its own reporting calendar and Business model. The discussion below retains company-reported financial measures and announced plans while separating those facts from assumptions about future outcomes.

Company Business

SKS Technologies Group Limited (ASX:SKS)

SKS Technologies Group Limited designs, supplies, installs and commissions electrical, communications and audio-visual systems, historically across commercial buildings, hospitals, education facilities, stadiums and industrial sites — what the company now calls its "traditional" division.

Epiminder Limited (ASX:EPI)

Epiminder Limited is a Melbourne-based medical technology company developing Minder, a minimally invasive implantable device for continuous electroencephalography — chronic EEG — in people with epilepsy. The device sits beneath the scalp and records brain activity continuously, replacing reliance on patient-kept seizure diaries, widely acknowledged unreliable.

Bathurst Resources Limited (ASX:BRL)

Bathurst operates four producing mines: Stockton, on the South Island's West Coast, is the export operation, producing metallurgical coal for international steelmaking markets, while Rotowaro and Maramarua in the North Island, and Takitimu in the South Island, serve the New Zealand domestic market. The first three are held through the BT Mining joint venture in which Bathurst holds 65%; Takitimu is wholly owned.

Financial Performance

SKS Technologies Group Limited (ASX:SKS)

The mix has changed materially over three years: data centre work is now the larger half of the group, covering high-voltage and low-voltage cabling, substation fit-outs, switchboards, power distribution units and installing and testing client-supplied transformers and generators for hyperscale facilities. SKS generally works as a subcontractor to major builders rather than the end operator, and reported a 95% repeat business rate in FY2026.

In January 2026 it completed the Acquisition of Delta Elcom, a Sydney electrical and communications contractor with roughly A$25 million in annual revenue, for A$10.5 million cash plus new shares and an earn-out of up to A$1.25 million — described by management as immaterial to FY2026 group results.

Epiminder Limited (ASX:EPI)

The company emerged from Australian research institutions including the Bionics Institute, the University of Melbourne and St Vincent's Hospital Melbourne, founded on work by neurologist Professor Mark Cook. Cochlear Limited holds a substantial shareholding — reported at approximately 36% — and manufactures the device; Rohan Hoare is chief executive. The Minder system holds US FDA approval and qualifies for breakthrough device designation, carrying reimbursement advantages, at a reported price of roughly USA$25,000.

Epiminder listed on the ASX on 1 December 2025, raising A$125 million through the issue of 83.3 million shares at A$1.50 each, valuing the company at approximately A$290 million on debut.

Bathurst Resources Limited (ASX:BRL)

Bathurst operates four producing mines: Stockton, on the South Island's West Coast, is the export operation, producing metallurgical coal for international steelmaking markets, while Rotowaro and Maramarua in the North Island, and Takitimu in the South Island, serve the New Zealand domestic market. The first three are held through the BT Mining joint venture in which Bathurst holds 65%; Takitimu is wholly owned.

Three development projects sit behind this: the wholly owned Buller Plateaux Continuation Project, about 17 kilometres from Stockton; Tenas, near Telkwa in British Columbia, wholly owned and targeting semi-soft coking coal; and Crown Mountain, also in British Columbia, held at a 22.8% economic interest with an option to increase to 50%. Export Earnings are linked to the Peak Downs hard coking coal benchmark, with Bathurst's coal realising around 70% to 80% of that benchmark and roughly one-third of production hedged.

Sector Context

The companies serve different parts of the small cap stocks economy, so their revenue and cost structures are not directly interchangeable. Contract duration, recurring income, customer concentration, Capital Expenditure and acquisition accounting can materially change how headline growth appears in each set of accounts.

A useful comparison therefore starts with the source of revenue and the cash required to support it. Reported guidance remains conditional on management execution, customer activity and the timing of announced projects or integrations.

Risks to Consider

SKS Technologies Group Limited (ASX:SKS)

Concentration is real: with data centres now the large majority of FY2026 revenue and pipeline, a slowdown in hyperscale construction or a deferred capacity decision would hit SKS harder than a diversified contractor. Management has flagged pipeline conversion as uncertain and dependent on external factors.

Epiminder Limited (ASX:EPI)

The central risk is that Epiminder generates no product revenue and depends on clinical and regulatory progress; slippage in enrolment, a safety signal, or a change in FDA requirements would push the commercial timeline further out.

Bathurst Resources Limited (ASX:BRL)

Commodity exposure cuts both ways: the benchmark's rapid swing in August 2026 shows how quickly the revenue assumption can change, and FY2027 guidance already assumes a softer outcome.

What to Watch Next

SKS Technologies Group Limited (ASX:SKS)

In November 2025 SKS received a letter of intent worth about A$130 million for a Melbourne hyperscale data centre; on 17 April 2026 that engagement was expanded to A$210 million — the largest single contract in the company's history — after the facility's capacity was lifted from 90MW to 126MW. The client is construction group Hickory, the site is MEL02A in Melbourne's west, and completion is scheduled for the third quarter of 2027.

In May 2026 the company announced a A$22 million Docklands headquarters contract alongside a A$20 million increase in bank facilities, lifting total facilities 62.5% to A$52 million; on 14 July 2026 SKS was awarded A$28 million of early works on the MEL2 hyperscale data centre in Melbourne's north-west for builder Built, covering substation works and high-voltage and low-voltage infrastructure.

Epiminder Limited (ASX:EPI)

The first US implant of the Minder system took place in January 2026 at the University of Pennsylvania as part of DETECT, the company's US pivotal program, with five US medical centres joining early, including three Mayo Clinic sites and Beth Israel Deaconess Medical Center.

DETECT reached its 25th enrolment around the start of June 2026, and on 16 July 2026 Epiminder announced the 50th enrolment, describing it as ahead of target. At the FY2026 result the company reported 20 participating medical centres, working toward up to 25, against a study target of 210 participants.

Bathurst Resources Limited (ASX:BRL)

On 21 August 2026 the company lodged its Buller Plateaux Continuation Project application under New Zealand's fast-track approvals process, designed for 1.1 to 1.2 million tonnes a year, with start-up capital of approximately NZA$100 million and production anticipated in late 2028 or 2029 across a project life reported at 25 years.

In Canada, the Tenas environmental certificate application has been submitted and is subject to a fixed 150-day assessment period followed by a 30-day decision period; the project targets about 750,000 tonnes a year of semi-soft coking coal, with first production aimed at 2029 subject to certification.

How to Read the Current Position

The clearest assessment will come from subsequent company reporting. Revenue should be read alongside margins and cash flow, while acquisition-led growth should be distinguished from organic activity. Guidance and longer-term targets are company objectives rather than assured outcomes.